InvestorQ : What is the significance of Biocon starting clinical trials for Itolizumab?
Angel dcosta made post

What is the significance of Biocon starting clinical trials for Itolizumab?

Answer
user profile image
Anamika Sodhani answered.
3 months ago


Biocon Biologics has started clinical trials for itolizumab to treat cytokine storms. This is important because cytokine storm is a leading cause of death among severe Covid-19 patients. The drug was launched in 2013 to treat plaque psoriasis. However, it is now repurposing the drug for prevention and treatment of covid-19 complications after seven years of post-marketing safety data. The DCGI (Drug Controller General of India) has allowed the company to run clinical trials in patients with Covid-19 complications. Cytokine Storm has been a key reason for morbidity and mortality in COVID-19 patients. In some cases, the Coronavirus infection causes overproduction of cytokines leading to multiple organ failure.